Catheter Precision (VTAK) announced that it has received CE Mark approval for LockeT, the latest advanced vascular closure device. Receipt of the CE Mark indicates compliance with European Union regulations, specifically health, safety, and environmental protection standards. With this approval, LockeT is now eligible to be placed in markets within the EU and additional countries such as the UK, Switzerland and Turkey. According to Market Data Forecast, The European Vascular Closure Devices Market in Europe was worth $3.1N in 2024 and is predicted to be worth $4.3B by 2028, growing at a CAGR of 7% from 2023 to 2028.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision Enters Market Offering Agreement
- Catheter Precision Enters Securities Purchase Agreement
- Catheter Precision announces $1.5M private placement equity financing
- Catheter Precision Finalizes Strategic Cardiac Acquisition
- Catheter Precision completes acquisition of Cardionomic heart failure assets
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue